Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Deutsche Bank Downgrades Wendy’s to Hold, Announces $23 Price Target

Deutsche Bank Downgrades Wendy’s to Hold, Announces $23 Price Target

Deutsche Bank analyst Brian Mullan downgrades Wendy's (NASDAQ:WEN) from Buy to Hold and announces $23 price target.

byBenzinga Newsdesk

January 17, 2023

1 minute read

Deutsche Bank analyst Brian Mullan downgrades Wendy’s (NASDAQ:WEN) from Buy to Hold and announces $23 price target.

Analyst Ratings

Where SilverBow Resources Stands With Analysts

By Benzinga Insights

August 15, 2:00 PM

Analysts have provided the following ratings for SilverBow Resources (NYSE:SBOW) within the last quarter: Bullish Somewhat Bullish Indifferent…

SBOW

PolyPid Announces Top-line Results Of Phase 3 SHIELD I Trial Of D-PLEX100 Did Not Achieve Its Primary Endpoint For The Prevention Of Surgical Site Infections In Abdominal Surgery

By Benzinga Newsdesk

September 2, 8:42 AM

SHIELD I Study did not Achieve its Primary Endpoint of Reduction in Surgical Site Infections and Mortality In an FDA Requested Pre-specified Subgroup Analysis in Subjects with Incision Lengths over 20 centimeters

PYPD

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,300 Today

By Benzinga Insights

July 17, 11:00 AM

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 20 years by 9.2% on an annualized…

TMO

Analyst Ratings

Analyst Ratings for Virtus Inv

By Benzinga Insights

October 23, 12:00 PM

Analysts have provided the following ratings for Virtus Inv (NASDAQ:VRTS) within the last quarter: Bullish Somewhat Bullish Indifferent…

VRTS

Deutsche Bank Downgrades Wendy’s to Hold, Announces $23 Price Target

Related Posts

Where SilverBow Resources Stands With Analysts

PolyPid Announces Top-line Results Of Phase 3 SHIELD I Trial Of D-PLEX100 Did Not Achieve Its Primary Endpoint For The Prevention Of Surgical Site Infections In Abdominal Surgery

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,300 Today

Analyst Ratings for Virtus Inv